Figure 3.

High expression of DLX6 is found in endometrial cancer. A, Expression profile of DLX6 analysed in GEPIA database. B, Correlation between DLX6‐AS1 and DLX6 analysed in GEPIA database. C, Relative expression of DLX6 in endometrial cancer tissues and normal tissues determined by RT‐qPCR. D, Relative expression of DLX6 in endometrial cancer tissues and normal tissues determined by Western blot analysis. E, Relative expression of DLX6 in endometrial cancer cell lines determined by Western blot analysis. F, Relative expression of DLX6 in endometrial cancer cells determined by Western blot analysis after silencing DLX6‐AS1. *P < 0.05 vs normal tissues or PA cells or sh‐NC treatment. The results were measurement data and expressed as mean ± standard deviation. Comparison between two groups was conducted by non‐paired t test. Comparison among multiples groups was conducted by one‐way analysis of variance, followed by Tukey's post hoc test. Cell experiment was repeated three times independently